Sapporo Clinical Laboratory Inc. (TYO:9776)

TYO:9776 Revenue

Sapporo Clinical Laboratory had revenue of 5.30B JPY in the quarter ending December 31, 2025, with 0.32% growth. This brings the company's revenue in the last twelve months to 20.39B, up 1.42% year-over-year. In the fiscal year ending March 31, 2025, Sapporo Clinical Laboratory had annual revenue of 20.13B with 2.28% growth.

• Revenue (ttm): 20.39B
• Revenue Growth: +1.42%
• P/S Ratio: 0.30
• Revenue / Employee: 23.20M
• Employees: 879
• Market Cap: 6.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	20.13B	449.00M	2.28%
Mar 31, 2024	19.68B	-445.00M	-2.21%
Mar 31, 2023	20.13B	1.02B	5.33%
Mar 31, 2022	19.11B	1.61B	9.18%
Mar 31, 2021	17.50B	-157.00M	-0.89%